These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
16 results:

  • 1. Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
    DiNardo CD; Lachowiez CA; Takahashi K; Loghavi S; Kadia T; Daver N; Xiao L; Adeoti M; Short NJ; Sasaki K; Wang SA; Borthakur G; Issa G; Maiti A; Alvarado Y; Pemmaraju N; Bravo GM; Masarova L; Yilmaz M; Jain N; Andreeff M; Garcia-Manero G; Kornblau S; Ravandi F; Jabbour E; Konopleva MY; Kantarjian HM
    Am J Hematol; 2022 Aug; 97(8):1035-1043. PubMed ID: 35583199
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.
    Wang J; Li Z; Yin F; Zhang R; Zhang Y; Wang Z; Sheng X
    Cancer Gene Ther; 2022 Mar; 29(3-4):253-263. PubMed ID: 33742130
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. mTOR kinase inhibition disrupts neuregulin 1-erbb3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.
    Beauchamp RL; Erdin S; Witt L; Jordan JT; Plotkin SR; Gusella JF; Ramesh V
    J Biol Chem; 2021; 296():100157. PubMed ID: 33273014
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.
    Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT
    J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
    Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
    Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Frontline Dasatinib treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid leukemia.
    Latagliata R; Stagno F; Annunziata M; Abruzzese E; Iurlo A; Guarini A; Fava C; Gozzini A; Bonifacio M; Sorà F; Leonetti Crescenzi S; Bocchia M; Crugnola M; Castagnetti F; Capodanno I; Galimberti S; Feo C; Porrini R; Pregno P; Rizzo M; Antolino A; Mauro E; Sgherza N; Luciano L; Tiribelli M; Russo Rossi A; Trawinska M; Vigneri P; Breccia M; Rosti G; Alimena G
    Neoplasia; 2016 Sep; 18(9):536-40. PubMed ID: 27659013
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of Nucleotide Synthesis Targets Brain Tumor Stem Cells in a Subset of Glioblastoma.
    Laks DR; Ta L; Crisman TJ; Gao F; Coppola G; Radu CG; Nathanson DA; Kornblum HI
    Mol Cancer Ther; 2016 Jun; 15(6):1271-8. PubMed ID: 27196770
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario.
    Torres S; Trudeau M; Eisen A; Earle CC; Chan KKW
    Breast Cancer Res Treat; 2015 Jul; 152(1):137-145. PubMed ID: 26026467
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes.
    Meyerhuber P; Conrad H; Stärck L; Leisegang M; Busch DH; Uckert W; Bernhard H
    J Mol Med (Berl); 2010 Nov; 88(11):1113-21. PubMed ID: 20700725
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium.
    Kettle R; Simmons J; Schindler F; Jones P; Dicker T; Dubois G; Giddings J; Van Heeke G; Jones CE
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):472-81. PubMed ID: 19556605
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
    Santegoets SJ; Schreurs MW; Masterson AJ; Liu YP; Goletz S; Baumeister H; Kueter EW; Lougheed SM; van den Eertwegh AJ; Scheper RJ; Hooijberg E; de Gruijl TD
    Cancer Immunol Immunother; 2006 Dec; 55(12):1480-90. PubMed ID: 16468034
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea.
    Bruchova H; Borovanova T; Klamova H; Brdicka R
    Leuk Lymphoma; 2002 Jun; 43(6):1289-95. PubMed ID: 12152998
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
    Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA
    Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia.
    DeNardo GL; Lewis JP; DeNardo SJ; O'Grady LF
    Cancer; 1994 Mar; 73(5):1425-32. PubMed ID: 8111709
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.